379 related articles for article (PubMed ID: 20332126)
21. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.
Boschin IM; Torresan F; Toniato A; Zane M; Ide EC; Pennelli G; Rampin L; Colletti PM; Rubello D; Pelizzo MR
Endocrine; 2014 Apr; 45(3):448-53. PubMed ID: 23884895
[TBL] [Abstract][Full Text] [Related]
22. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
[TBL] [Abstract][Full Text] [Related]
23. [Calcitonin determination for early diagnosis of medullary thyroid cancer].
Karges W
Chirurg; 2010 Jul; 81(7):620, 622-6. PubMed ID: 20549176
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.
Verbeek HH; de Groot JWB; Sluiter WJ; Muller Kobold AC; van den Heuvel ER; Plukker JT; Links TP
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010159. PubMed ID: 32176812
[TBL] [Abstract][Full Text] [Related]
25. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
26. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
27. [Recommendation for Calcitonin Screening in Nodular Goiter].
Frank-Raue K; Schott M; Raue F;
Dtsch Med Wochenschr; 2018 Aug; 143(15):1065-1069. PubMed ID: 30060274
[TBL] [Abstract][Full Text] [Related]
28. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
29. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter.
Ozgen AG; Hamulu F; Bayraktar F; Yilmaz C; Tüzün M; Yetkin E; Tunçyürek M; Kabalak T
Thyroid; 1999 Jun; 9(6):579-82. PubMed ID: 10411120
[TBL] [Abstract][Full Text] [Related]
31. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
[TBL] [Abstract][Full Text] [Related]
32. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.
Chambon G; Alovisetti C; Idoux-Louche C; Reynaud C; Rodier M; Guedj AM; Chapuis H; Lallemant JG; Lallemant B
J Clin Endocrinol Metab; 2011 Jan; 96(1):75-81. PubMed ID: 20881258
[TBL] [Abstract][Full Text] [Related]
33. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
[TBL] [Abstract][Full Text] [Related]
34. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
35. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin.
Scheuba C; Kaserer K; Kotzmann H; Bieglmayer C; Niederle B; Vierhapper H
Thyroid; 2000 May; 10(5):413-6. PubMed ID: 10884188
[TBL] [Abstract][Full Text] [Related]
37. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.
Lorenz K; Elwerr M; Machens A; Abuazab M; Holzhausen HJ; Dralle H
Langenbecks Arch Surg; 2013 Mar; 398(3):403-9. PubMed ID: 23408061
[TBL] [Abstract][Full Text] [Related]
39. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
40. [Early diagnosis of sporadic medullary cancers of the thyroid: value of systematic assay of calcitonin].
Henry JF; Denizot A; Puccini M; Niccoli P; Conte-Devolx B; de Micco C
Presse Med; 1996 Nov; 25(33):1583-8. PubMed ID: 8952672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
